What is Ajax Therapeutics worth?
$192.5Mlast known valuation
Ajax Therapeutics last raised $95.0M in its Later Stage VC (Series C) (May 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Ajax Therapeutics
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2024 | Later Stage VC (Series C) | $95.0M | ▮ | ▮ |
| May 2021 | Early Stage VC | $37.4M | ▮ | ▮ |
| Jun 2019 | Early Stage VC | $8.0M | ▮ | ▮ |
How Ajax Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Ajax Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Ajax Therapeutics worth?
- Ajax Therapeutics's last known valuation is $192.5M.
- How much has Ajax Therapeutics raised?
- Ajax Therapeutics has raised $143.0M in total funding across 3 recorded rounds.
- When did Ajax Therapeutics last raise?
- Ajax Therapeutics last raised in May 2024 (Later Stage VC (Series C)), raising $95.0M.